Page 44 of 95 FirstFirst ... 34353637383940414243444546474849505152535494 ... LastLast
Results 431 to 440 of 941

Thread: Spinal Cord Injury Articles Posted by Manouli

  1. #431
    they are improving all the time, I wish they can do this to our spinal cord. Can they?


    News Release
    Date: June 15, 2012
    New Surgical Technique May Reverse Paralysis, Restore Use of Hand

    Justin M. Brown, MD, reconstructive neurosurgeon at UC San Diego Health System, is one of only a few specialists in the world who have pioneered a novel technique to restore hand function in patients with spinal cord injury. In a delicate four-hour procedure, Brown splices together tiny nerve endings, only one millimeter in width, to help restore hand mobility. Most patients return home 24 hours after surgery.

    "Even if a patient appears to have lost total hand function, as long as there is some nerve in the arm or shoulder under the patient’s control, some mobility may be regained,” said Brown, director of the Neurosurgery Peripheral Nerve Program and co-director of the Center for Neurophysiology and Restorative Neurology at UC San Diego Health System. “With a nerve transfer, the goal is to reverse paralysis. This means achieving functional grasp and release so that patients can eat independently, operate a computer or hold a loved one’s hand.”

    read...

    http://health.ucsd.edu/news/releases...paralysis.aspx

  2. #432
    He is working on both acute and chronic spinal cord injury, that's a good thing. Also, he is always reporting what he is up too.


    InVivo Therapeutics' CEO Frank Reynolds Scheduled to Appear on WAWS-TV (FOX)/WTEV-TV (CBS) in Jacksonville and KNSD-TV (NBC) in San Diego CEO to Discuss Latest Advances on June 25, 2012 and June 26, 2012
    Published: Thursday, 21 Jun 2012 | 6:00 AM ET
    Text Size

    CAMBRIDGE, Mass., Jun 21, 2012 (BUSINESS WIRE) -- InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that CEO Frank Reynolds is scheduled to appear on WAWS-TV (FOX)/WTEV-TV (CBS) in Jacksonville, Florida on Monday June 25, 2012 at 7:45 am EDT. He is also scheduled to appear on KNSD-TV (NBC) in San Diego, California on Tuesday June 26, 2012 at 12:00pm PDT.

    InVivo Therapeutics has pioneered a new treatment using a biocompatible polymer-based scaffold to provide structural support to a damaged spinal cord.

    The device spares spinal cord tissue from scarring while improving functional recovery after a traumatic SCI. In addition to the scaffold and its application for acute and chronic SCI, Reynolds will discuss new hydrogel technologies under development by InVivo.

    read...

    http://www.cnbc.com/id/47900861/InVi...d_June_26_2012

  3. #433
    Ekso Bionics raises $9 million
    San Francisco Business Times by Patrick Hoge, Reporter
    Date: Friday, June 22, 2012, 1:37pm PDT

    Patrick Hoge
    Reporter- San Francisco Business Times
    Email | Twitter
    Ekso Bionics, maker of mechanical exoskeletons for use by people with spinal cord injuries, raised $9 million according to a regulatory filing.

    The Richmond company, which previously was known as Berkeley Bionics and recently moved its headquarters from Berkeley, shipped the first $125,000 Ekso unit in February to Craig Hospital in Denver, Colo., following a 10 month study in 11 rehabilitation hospitals, including the Santa Clara Valley Medical Center Santa Clara Valley Medical Center Latest from The Business Journals Search on for Valley Med CEO replacement after Smith outTransparency lacking in VMC exec’s firingSurprises not uncommon when developers dig in Follow this company in San Jose. It has since sold numerous other machines.

    read....

    http://www.bizjournals.com/sanfranci...dustry+News%29

  4. #434
    good news.



    Asubio Initiates Landmark Clinical Study in Spinal Cord Injury


    Long-term commitment to evaluating the impact of SUN13837 on neurological function discussed at American Spinal Injury Association symposium
    PARAMUS, N.J., April 23, 2012 /PRNewswire/ -- Today, Asubio announced the initiation of a landmark Phase 2 clinical trial of SUN13837, an investigational medication being developed to improve neurological function in patients with newly diagnosed acute spinal cord injury.

    In accordance with its internal focus on scientific rigor, Asubio recently discussed its endpoint development activities at a peer-attended symposium at the American Spinal Injury Association (ASIA) annual meeting. The company also reinforced its long-term strategic and financial commitment to completing the clinical trial.

    Asubio is working with 60 acute trauma centers throughout the United States and Canada to enroll 164 patients in the clinical trial. Trauma centers must first sign on to participate in the study, and then attending trauma physicians and nurses will identify eligible patients when they arrive at a facility with a spinal cord injury. Physicians or trauma center representatives can write Ben Levinson at blevinson@asubio.com for more information about participation, or visit ClinicalTrials.gov (NCT01502631).

    "Valid clinical trial programs, such as the acute spinal cord injury study being supported by Asubio provide an objective path to understanding and improving life after spinal cord injury," said John Steeves, PhD, Peter Wall Distinguished Scholar in Residence, Professor and Founding Director of ICORD (International Collaboration On Repair Discoveries). "I encourage all Level One Trauma Centers to consider informing and enrolling appropriate participants."

    more....

    http://www.prnewswire.com/news-relea...148501325.html

  5. #435

    Neuroprotective dietary supplements for chronic spinal cord injury

    Public release date: 26-Jun-2012
    [ Print | E-mail | Share ] [ Close Window ]

    Contact: Gillian Shasby
    gshasby@thejns.org
    434-924-5555
    Journal of Neurosurgery Publishing Group

    Neuroprotective dietary supplements for chronic spinal cord injury



    Charlottesville, VA (June 26, 2012). Researchers from the Department of Neurosurgery at the David Geffen School of Medicine and the Department of Integrative Biology and Physiology at UCLA have found that a diet enriched with docosahexaenoic acid (DHA), an omega-3 fatty acid, and curcumin, a component of the Indian spice turmeric, can protect the injured spinal cord and minimize the clinical and biochemical effects of spinal cord myelopathy in rats. This finding is fleshed out in the article "Dietary therapy to promote neuroprotection in chronic spinal cord injury. Laboratory investigation," by Langston Holly, M.D., and colleagues, published today online in the Journal of Neurosurgery: Spine. DHA reduces inflammation and provides structural material to plasma membranes. Curcumin produces strong anti-inflammatory and antioxidant effects. Both agents are safe to use and have been documented to have positive effects on the injured brain. Thus the researchers hypothesized that the combined effects of DHA and curcumin could protect the spinal cord from the cascade of cellular and related biological injuries that result from chronic cord injury.

    read...

    http://www.eurekalert.org/pub_releas...-nds062212.php


    Curry Spice, Omega-3 Fatty Acid Preserve Walking Ability Following Spinal-Cord Injury

    ScienceDaily (June 26, 2012) — UCLA researchers discovered that a diet enriched with a popular omega-3 fatty acid and an ingredient in curry spice preserved walking ability in rats with spinal-cord injury. Published June 26 in the Journal of Neurosurgery: Spine, the findings suggest that these dietary supplements help repair nerve cells and maintain neurological function after degenerative damage to the neck.

    read...
    http://www.sciencedaily.com/releases...0626113930.htm
    Last edited by manouli; 06-27-2012 at 11:05 AM.

  6. #436
    Robotic Balance Training System Assists Local Spinal Cord Injury Patients



    AUSTIN, Texas - (July 3, 2012) - The Seton Brain & Spine Recovery Center, a member of the Seton Healthcare Family, is helping those with spinal cord injuries get one step closer to being able to walk with a new, state-of-the-art piece of rehabilitation equipment.

    The ZeroG System, the only one in Central Texas, is a balance training technology which provides body-weight support. It helps with a person's posture, balance and ability to move about independently.

    The new technology is the first-ever gait and balance-assisted robotic system. Walking in the ZeroG is similar to walking in a reduced gravity environment. The device can detect if a person starts to fall forward or backward and will catch them so they are not injured.

    The computerized brain of the system makes up to 1,200 adjustments per second.
    It uses a sophisticated pulley system capable of holding up to 350 pounds.

    read...

    http://www.seton.net/about_seton/new...njury_patients

  7. #437

    Wink

    I thought they know about this a couple of years ago.


    Zebrafish Reveal Promising Process for Healing Spinal Cord Injury


    ScienceDaily (July 6, 2012) — Yona Goldshmit, Ph.D., is a former physical therapist who worked in rehabilitation centers with spinal cord injury patients for many years before deciding to switch her focus to the underlying science.

    "After a few years in the clinic, I realized that we don't really know what's going on," she said.

    Now a scientist working with Peter Currie, Ph.D., at Monash University in Australia, Dr. Goldshmit is studying the mechanisms of spinal cord repair in zebrafish, which, unlike humans and other mammals, can regenerate their spinal cord following injury. On June 23 at the 2012 International Zebrafish Development and Genetics Conference in Madison, Wisconsin, she described a protein that may be a key difference between regeneration in fish and mammals

    One of the major barriers to spinal regeneration in mammals is a natural protective mechanism, which incongruously results in an unfortunate side effect. After a spinal injury, nervous system cells called glia are activated and flood the area to seal the wound to protect the brain and spinal cord. In doing so, however, the glia create scar tissue that acts as a physical and chemical barrier, which prevents new nerves from growing through the injury site.

    read...

    http://www.sciencedaily.com/releases...0706184353.htm

  8. #438
    From the boss's mouth.



    InVivo Therapeutics Protects And Regenerates The Spinal Cord Resulting in Functional Improvement Below the Injury
    Written by Herina Ayot on Jun 21, 2012


    Frank Reynolds, of InVivo Therapeutics (NVIV), says the company is on the verge of unprecedented technology for the treatment of the spinal cord. The Massachusetts-based medical device company is developing regenerative and neuroprotective technologies for the treatment of spinal cord injuries. It is the first company in history to successfully demonstrate functional improvement in a paralyzed non-human primate.
    Below OneMedRadio interviews Reynolds where he speaks candidly about his own injury rendering him a paraplegic, and the passion behind his work. Reynolds will be presenting InVivo’s technology at OneMedForum New York on July 12, 2012.

    Click below to hear audio interview and see full transcript that follows.



    http://www.onemedplace.com/blog/archives/11528

  9. #439
    does this mean that we are not profitable to them?


    July 13, 2012 05:24 AM Eastern Daylight Time
    Research and Markets: Acute Spinal Cord Injury (ASCI) Therapeutics - Pipeline Assessment and Market Forecasts to 2019

    DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/re...te_spinal_cord) has announced the addition of GlobalData's new report "Acute Spinal Cord Injury (ASCI) Therapeutics - Pipeline Assessment and Market Forecasts to 2019" to their offering.



    Pharmaceutical Research into Spinal Cord Injuries Will Stretch into Next Decade

    Drugs under development to treat those affected by acute spinal cord injuries are not expected to emerge within the current decade, leaving the market largely open to new entrants, according to a new report issued by pharmaceuticals intelligence provider GlobalData.

    The new report* shows that there have been no treatment options approved for Acute Spinal Cord Injury (ASCI) by either the Food and Drug Administration (FDA) or the European Medicines Agency (EMA), so off-label generic drugs dominate the market.

    more...

    http://www.businesswire.com/portal/s...00639&vnsId=41

  10. #440

    A bone of contention for the ailing

    something new here?



    A bone of contention for the ailing
    July 14, 2012
    By Cynthia Chandran
    DC
    Thiruvananthapuram
    Tags:
    accidents, bone marrow, health care

    Some 35,216 road accidents left 4,145 people dead and thousands injured in the state last year. While its known that 20,000 suffer spinal cord injuries every year as a result of road accidents and falls from great heights in the country, no similar statistics are available for Kerala.

    But what is known is that hundreds of accident victims with spinal cord injuries in the state are having a tough time making ends meet in the absence of government aid and delay in settling of their insurance claims by the Motor Accident Claim Tribunal (MACT).

    In the midst of it all , a debate is now raging on whether those who have lost the use of their limbs and are leading lives either as paraplegics or quadraplegics should rely on the bio-modulation of bone marrow treatment being popularised by Kottayam orthopaedist, Dr. P. S. John and bio-technologist, Dr. C. S. Poulose.

    Dr. John , a former professor and head of department of orthopaedics at the Kottayam Medical College and Dr. Poulose, professor, department of bio-technology, CUSAT, claim they have successfully conducted trials on animals since early 2000 and have got the patented technology for their treatment, which they call bio-modulation of bone marrow.

    read...

    http://www.deccanchronicle.com/chann...ion-ailing-404

Similar Threads

  1. Replies: 0
    Last Post: 08-14-2005, 09:16 AM
  2. New articles posted to Research Forums.
    By Wise Young in forum Cure
    Replies: 1
    Last Post: 04-15-2004, 11:41 AM
  3. Replies: 0
    Last Post: 01-14-2004, 12:00 PM
  4. Replies: 8
    Last Post: 05-15-2003, 02:05 AM
  5. Replies: 1
    Last Post: 05-12-2002, 04:07 PM

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •